CUSIP: 38341P102
Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
235,780,191
-
Total 13F shares
-
171,313,829
-
Share change
-
-4,480,924
-
Total reported value
-
$154,975,691
-
Put/Call ratio
-
68%
-
Price per share
-
$0.90
-
Number of holders
-
102
-
Value change
-
-$4,643,111
-
Number of buys
-
43
-
Number of sells
-
39
Quarterly Holders Quick Answers
What is CUSIP 38341P102?
CUSIP 38341P102 identifies GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2025
-
Previous quarter:
Q3 2024
Recent filing periods for CUSIP 38341P102:
Institutional Holders of Gossamer Bio, Inc. - Common Stock, $0.0001 par value per share (GOSS) as of Q4 2024
As of 31 Dec 2024,
Gossamer Bio, Inc. - Common Stock, $0.0001 par value per share (GOSS) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
171,313,829 shares.
The largest 10 holders included
Octagon Capital Advisors LP, NEA Management Company, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., ARCH Venture Management, LLC, FMR LLC, 683 Capital Management, LLC, Palo Alto Investors LP, SILVERARC CAPITAL MANAGEMENT, LLC, and Samsara BioCapital, LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.